Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Haleon plc is a consumer healthcare company that focuses on the development, manufacturing, and distribution of health products. The company operates in the healthcare industry, specifically targeting wellness and over-the-counter products. Haleon's portfolio includes well-known brands such as Sensodyne, Advil, and Centrum, which are aimed at providing solutions for oral health, pain relief, and dietary supplementation. Headquartered in the United Kingdom, the company maintains a global presence with a significant geographic footprint in numerous markets. Haleon's strategic positioning lies in its focus on scientifically backed consumer health products and a robust brand portfolio, which supports its competitive presence in the healthcare sector.
View stock
VS
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stock

Stock highlights

Stock comparison highlights
Stock name
Haleon plcAbbVie
Last price
£3.21$294.51
Currency
GBP
USD
£28B$514B
17.4882.15
£0.18$3.54
0.250.28
£0.07$6.83
2.31%2.38%
Sector
HealthHealth
Employees
24,53557,000
Ticker
£HLN$ABBV
Primary listing
LSENYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in £HLN or $ABBV on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.